| Date Filed | Type | Description |
| 05/18/2023 |
4/A
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 5,000 shares
@ $4.58, valued at
$22.9k
|
|
| 05/17/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 5,000 shares
@ $4.58, valued at
$22.9k
|
|
| 05/12/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Paid exercise price by delivering 37,443 shares
@ $5.3, valued at
$198.4k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 20,000 shares
@ $3.82, valued at
$76.4k
|
|
| 08/25/2022 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 4,700 shares
@ $3.92, valued at
$18.4k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Todisco Joseph (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,562 shares
@ $5.2, valued at
$8.1k
Exercised 4,441 restricted stock units
@ $0 |
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,212 shares
@ $3.55, valued at
$7.9k
Exercised 4,442 restricted stock units
@ $0 |
|
| 03/03/2020 |
4
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 40,000 shares
@ $3.62, valued at
$144.8k
Paid exercise price by delivering 6,162 shares
@ $3.85, valued at
$23.7k
Exercised 11,111 restricted stock units
@ $0 |
|
| 03/02/2020 |
4
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 118,734 restricted stock units
@ $0
Granted 237,468 options to buy
@ $0 |
|
| 02/14/2020 |
5
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 5 on Amneal Pharmaceuticals, Inc. |
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2019 |
4
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $9.88, valued at
$148.2k
|
|
| 05/09/2019 |
4
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,228 shares
@ $13.44, valued at
$29.9k
Exercised 4,441 restricted stock units
@ $0 |
|
| 05/07/2019 |
3
| Todisco Joseph (SVP, Specialty Commercial) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |